ArriVent BioPharma (AVBP) Cash & Current Investments (2023 - 2026)
ArriVent BioPharma (AVBP) recorded Cash & Current Investments of $373.12 million in Q2 2026, up 58.3% from $235.69 million a year earlier and up 14.3% from the prior quarter.
Powered by 
Analysis
ArriVent BioPharma (AVBP) Cash & Current Investments (2023 - 2026) Analysis & Trends
At the end of FY2025, ArriVent BioPharma reported Cash & Current Investments of $312.82 million, up 42.9% from FY2024.
- Across earlier years, Cash & Current Investments came in at $218.86 million in FY2024 (+45.5%) and $150.39 million in FY2023.
- The Q2 2026 figure is the highest quarterly Cash & Current Investments in data going back to Q4 2023.
- On a year-over-year basis, Cash & Current Investments has increased for four consecutive quarters, with growth averaging 24.7% over the last seven quarters.
- Per Business Quant, the preceding three quarters came in at $326.38 million (Q1 2026), $312.82 million (Q4 2025) and $300.27 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 11.70 Bn |
| 10 | ArriVent BioPharma | 1.00 Bn | -311.41 Mn | - | 373.12 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 373.12 Mn |
| Mar 31, 2026 | 326.38 Mn |
| Dec 31, 2025 | 312.82 Mn |
| Sep 30, 2025 | 300.27 Mn |
| Jun 30, 2025 | 235.69 Mn |
| Mar 31, 2025 | 176.08 Mn |
| Dec 31, 2024 | 218.86 Mn |
| Sep 30, 2024 | 282.90 Mn |
| Jun 30, 2024 | 298.70 Mn |
| Mar 31, 2024 | 317.40 Mn |
| Dec 31, 2023 | 150.39 Mn |
API Access
ArriVent BioPharma Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=AVBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "AVBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=AVBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();